|
US6093723A
(en)
|
1996-08-09 |
2000-07-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
4-substituted beta-carbolines and analogs thereof
|
|
AU751139B2
(en)
|
1997-10-13 |
2002-08-08 |
Astellas Pharma Inc. |
Amide derivative
|
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
|
CA2327185A1
(en)
|
1998-04-08 |
1999-10-14 |
Abbott Laboratories |
Pyrazole inhibitors of cytokine production
|
|
CA2332957A1
(en)
|
1998-06-05 |
1999-12-09 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
|
|
US20010044445A1
(en)
|
1999-04-08 |
2001-11-22 |
Bamaung Nwe Y. |
Azole inhibitors of cytokine production
|
|
BR0013469B1
(pt)
|
1999-08-20 |
2011-01-25 |
|
amidas aromáticas heterocìclicas fungicidas, composição fungicida compreendendo as mesmas, bem como método para o controle ou a prevenção de infestação fúngica.
|
|
JP3910319B2
(ja)
|
1999-09-13 |
2007-04-25 |
株式会社小糸製作所 |
自動車用灯具
|
|
EP1143013A1
(en)
|
2000-04-03 |
2001-10-10 |
Warner-Lambert Company |
Methods and compositions for screening Icrac modulators
|
|
GB0225554D0
(en)
|
2002-11-01 |
2002-12-11 |
Syngenta Participations Ag |
Chemical compounds
|
|
ES2571779T3
(es)
|
2002-12-13 |
2016-05-26 |
Ym Biosciences Australia Pty |
Inhibidores de cinasa a base de nicotinamida
|
|
WO2004056774A2
(en)
|
2002-12-19 |
2004-07-08 |
Neurogen Corporation |
Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
|
|
US7645588B2
(en)
|
2003-03-04 |
2010-01-12 |
Calcimedica, Inc. |
Composition comprising a cell comprising a STIM1 protein and an agent that modulates intracellular calcium and methods of use
|
|
HRP20110180T1
(hr)
|
2003-07-23 |
2011-04-30 |
Synta Pharmaceuticals Corporation |
Spojevi za upotrebu kod upala i upotrebe vezane uz imunitet
|
|
DE102004005785A1
(de)
|
2004-02-06 |
2005-08-25 |
Bayer Cropscience Ag |
2-Halogenfuryl/thienyl-3-carboxamide
|
|
MX2007003342A
(es)
|
2004-09-21 |
2007-06-05 |
Synta Pharmaceutical Corp |
Compuestos para inflamacion y usos relacionados con trastornos inmunitarios.
|
|
KR20140018997A
(ko)
|
2005-01-07 |
2014-02-13 |
신타 파마슈티칼스 코프. |
염증 및 면역 관련 용도를 위한 화합물
|
|
US8802721B2
(en)
|
2005-01-25 |
2014-08-12 |
Synta Pharmaceuticals Corp. |
Thiophene compounds for inflammation and immune-related uses
|
|
TWI422376B
(zh)
|
2005-01-25 |
2014-01-11 |
Synta Pharmaceuticals Corp |
用於炎症及免疫相關用途之化合物
|
|
BRPI0607688A2
(pt)
|
2005-02-17 |
2009-09-22 |
Synta Pharmaceuticals Corp |
método para inibir a polimerização de tubulina em uma célula; método para tratar ou prevenir um distúrbio proliferativo em um indivìduo; método para bloquear, ocluir ou de outro modo romper o fluxo sangüìneo na neovasculatura; composto; composição farmacêutica e uso do referido método e composto
|
|
EP2527337A1
(en)
|
2005-04-14 |
2012-11-28 |
Bristol-Myers Squibb Company |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
|
|
EP1937270A1
(en)
|
2005-09-21 |
2008-07-02 |
Brystol-Myers Squibb Company |
Oral administration of n-(2-chloro-6-methylphenyl)-2-[[6-4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof
|
|
NL2000284C2
(nl)
|
2005-11-04 |
2007-09-28 |
Pfizer Ltd |
Pyrazine-derivaten.
|
|
ES2778846T3
(es)
|
2005-11-08 |
2020-08-12 |
Vertex Pharma |
Moduladores heterocíclicos de transportadores de casete de unión a ATP
|
|
EP1984400B1
(en)
|
2006-01-05 |
2012-11-28 |
Immune Disease Institute, Inc. |
Regulators of nfat
|
|
WO2007087429A2
(en)
|
2006-01-25 |
2007-08-02 |
Synta Pharmaceuticals Corp. |
Phenyl and pyridyl compounds for inflammation and immune-related uses
|
|
WO2007087427A2
(en)
|
2006-01-25 |
2007-08-02 |
Synta Pharmaceuticals Corp. |
Thiazole and thiadiazole compounds for inflammation and immune-related uses
|
|
US7816535B2
(en)
|
2006-01-25 |
2010-10-19 |
Synta Pharmaceuticals Corp. |
Vinyl-phenyl derivatives for inflammation and immune-related uses
|
|
JP2009528273A
(ja)
|
2006-01-25 |
2009-08-06 |
シンタ ファーマシューティカルズ コーポレーション |
炎症および免疫関連使用用の置換ビアリール化合物
|
|
AU2007208239B2
(en)
|
2006-01-25 |
2013-04-18 |
Synta Pharmaceuticals Corp. |
Substituted aromatic compounds for inflammation and immune-related uses
|
|
JP5430944B2
(ja)
|
2006-01-31 |
2014-03-05 |
シンタ ファーマシューティカルズ コーポレーション |
炎症および免疫関連用途のためのピリジルフェニル化合物
|
|
US7951824B2
(en)
|
2006-02-17 |
2011-05-31 |
Hoffman-La Roche Inc. |
4-aryl-pyridine-2-carboxyamide derivatives
|
|
EP2001476A4
(en)
|
2006-03-20 |
2010-12-22 |
Synta Pharmaceuticals Corp |
BENZOIMIDAZOLYL-PARAZINE-BASED COMPOUNDS FOR INFLAMMATION USES AND IMMUNE DISORDERS
|
|
AU2007230911A1
(en)
|
2006-03-23 |
2007-10-04 |
Synta Pharmaceuticals Corp. |
Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
|
|
WO2007120600A2
(en)
|
2006-04-10 |
2007-10-25 |
Arena Pharmaceuticals, Inc. |
3-pyridinyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
|
MX2009000286A
(es)
|
2006-06-26 |
2009-03-20 |
Procter & Gamble |
Inhibidores de prolil hidroxilasa y metodos de uso.
|
|
AU2007322116B2
(en)
|
2006-11-13 |
2013-01-10 |
Synta Pharmaceuticals Corp. |
Cyclohexenyl-aryl compounds for inflammation and immune-related uses
|
|
EP2129219A4
(en)
|
2007-02-16 |
2012-08-29 |
Synta Pharmaceuticals Corp |
SUBSTITUTED FUSED CYCLE COMPOUNDS USED IN CASES OF INFLAMMATION OR IMMUNE DISORDERS
|
|
DK2157979T3
(en)
|
2007-05-24 |
2018-08-27 |
Calcimedica Inc |
CALCIUM CHANNEL PROTEINS AND APPLICATIONS THEREOF
|
|
EP2184994B1
(en)
|
2007-08-01 |
2013-09-25 |
Synta Pharmaceuticals Corp. |
Heterocycle-aryl compounds for inflammation and immune-related uses
|
|
TW200914440A
(en)
|
2007-08-01 |
2009-04-01 |
Synta Pharmaceuticals Corp |
Vinyl-aryl derivatives for inflammation and immune-related uses
|
|
JP2010535769A
(ja)
|
2007-08-09 |
2010-11-25 |
メルク・シャープ・エンド・ドーム・コーポレイション |
ピリジンカルボキサミドオレキシン受容体アンタゴニスト
|
|
US8263641B2
(en)
|
2007-09-10 |
2012-09-11 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
US20110052643A1
(en)
|
2008-01-07 |
2011-03-03 |
Synta Pharmaceuticals Corp. |
Compounds for inflammation and immune-related uses
|
|
FR2927330B1
(fr)
*
|
2008-02-07 |
2010-02-19 |
Sanofi Aventis |
Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antagonistes des recepteurs a l'urotensine ii
|
|
US20110003859A1
(en)
|
2008-02-29 |
2011-01-06 |
Array Biopharma Inc. |
N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer
|
|
AU2009227050A1
(en)
|
2008-03-20 |
2009-09-24 |
Csl Behring Gmbh |
The calcium sensor STIM1 and the platelet SOC channel Orai1 (CRACM1) are essential for pathological thrombus formation
|
|
US20100016598A1
(en)
|
2008-07-16 |
2010-01-21 |
Wyeth |
Alpha7 nicotinic acetylcholine receptor inhibitors
|
|
EP2321303B1
(en)
|
2008-08-27 |
2019-11-27 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
US8524763B2
(en)
|
2008-09-22 |
2013-09-03 |
Calcimedica, Inc. |
Inhibitors of store operated calcium release
|
|
WO2010034011A2
(en)
|
2008-09-22 |
2010-03-25 |
Calcimedica, Inc. |
Phenylthiophenyldihydrobenzothiazepine inhibitors of store operated calcium release
|
|
AU2009300318A1
(en)
|
2008-10-01 |
2010-04-08 |
Synta Pharmaceuticals Corp. |
Compounds for inflammation and immune-related uses
|
|
WO2010039237A1
(en)
|
2008-10-01 |
2010-04-08 |
Synta Pharmaceuticals Corp. |
Compounds for inflammation and immune-related uses
|
|
US20110230536A1
(en)
|
2008-10-24 |
2011-09-22 |
Calcimedica, Inc. |
Phenylpyrazole inhibitors of store operated calcium release
|
|
EP2421834A1
(en)
|
2009-04-24 |
2012-02-29 |
Glaxo Group Limited |
Pyrazole and triazole carboxamides as crac channel inhibitors
|
|
US20100273744A1
(en)
|
2009-04-24 |
2010-10-28 |
Paul Martin Gore |
Compounds
|
|
US8618307B2
(en)
|
2009-09-16 |
2013-12-31 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
US8377970B2
(en)
|
2009-10-08 |
2013-02-19 |
Rhizen Pharmaceuticals Sa |
Modulators of calcium release-activated calcium channel
|
|
US8993612B2
(en)
|
2009-10-08 |
2015-03-31 |
Rhizen Pharmaceuticals Sa |
Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
|
|
US20120231006A1
(en)
|
2009-11-20 |
2012-09-13 |
Amgen Inc. |
Anti-orai1 antigen binding proteins and uses thereof
|
|
JP5748777B2
(ja)
|
2010-02-02 |
2015-07-15 |
ノバルティス アーゲー |
Ｃｒｆ受容体アンタゴニストとしてのシクロヘキシルアミド誘導体
|
|
US10703722B2
(en)
|
2010-04-27 |
2020-07-07 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
JP2013525448A
(ja)
|
2010-04-27 |
2013-06-20 |
カルシメディカ，インク． |
細胞内カルシウムを調節する化合物
|
|
WO2011139489A2
(en)
|
2010-04-27 |
2011-11-10 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|
|
AU2011293201B2
(en)
|
2010-08-27 |
2015-11-05 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|
|
CN103702665B
(zh)
*
|
2011-05-03 |
2016-08-17 |
幸讬制药公司 |
用于炎症和免疫相关用途的化合物
|
|
WO2012170951A2
(en)
|
2011-06-10 |
2012-12-13 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
WO2012170931A2
(en)
|
2011-06-10 |
2012-12-13 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
CA2853469A1
(en)
|
2011-10-19 |
2013-04-25 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
WO2013059677A1
(en)
|
2011-10-19 |
2013-04-25 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
WO2013164769A1
(en)
|
2012-05-02 |
2013-11-07 |
Lupin Limited |
Substituted pyridine compounds as crac modulators
|
|
WO2014043715A1
(en)
|
2012-09-17 |
2014-03-20 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
WO2014059333A1
(en)
|
2012-10-12 |
2014-04-17 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
AR103807A1
(es)
|
2015-02-27 |
2017-06-07 |
Calcimedica Inc |
Tratamiento de la pancreatitis
|
|
JP6738575B2
(ja)
|
2015-08-07 |
2020-08-12 |
カルシメディカ，インク． |
脳卒中および外傷性脳損傷の処置のためのｃｒａｃチャネル阻害剤の使用
|
|
CA3051420A1
(en)
|
2017-01-26 |
2018-08-02 |
Calcimedica, Inc. |
Crac channel inhibitor compositions
|